Back |
home / stock / prog / prog message board
Subject | By | Source | When |
---|---|---|---|
I do believe today is the last day | foti1kenobi | investorshub | 12/29/2021 5:41:42 PM |
A company with a patent on taking injectable | foti1kenobi | investorshub | 12/29/2021 5:38:35 PM |
Yeah from $5 down to 1.8 in only | Torez | investorshub | 12/29/2021 5:01:19 PM |
Just panic selling. The price will rise gradually. | ttottip | investorshub | 12/29/2021 3:23:28 PM |
$1 will come fast now lol . | Torez | investorshub | 12/29/2021 2:42:20 PM |
Lol yup since $3 | Torez | investorshub | 12/29/2021 1:47:28 PM |
Good morning all ! Waiting for the short squeeze. | ttottip | investorshub | 12/29/2021 1:14:45 PM |
Welcome to 1s | Torez | investorshub | 12/29/2021 11:39:02 AM |
No you said - tomorrow very green | Torez | investorshub | 12/28/2021 9:07:16 PM |
prog on sale now. buy, buy, buy. | Stockman1010101 | investorshub | 12/28/2021 9:01:53 PM |
it could. I do not look at it | Stockman1010101 | investorshub | 12/28/2021 8:41:30 PM |
Dont get too cocky buddy - only 3%, | Torez | investorshub | 12/28/2021 4:29:40 PM |
News, Short Squeeze, Breakout and More Instantly...
Progenity Inc. Company Name:
PROG Stock Symbol:
NASDAQ Market:
Pharmacokinetic and tissue data confirm NaviCap platform delivers topically through the entire colon, with lower systemic concentrations, as desired Data modeling suggests tofacitinib tissue concentrations greater than IC90 through at least 16 hours after dosing SAN DIEGO, July 18...
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced further details on its virtual event to be held on Wednesday, July 17, 2024. The event will feature Bruce Sands, MD, MS (Icahn School of ...
Drug-device combination leverages Biora’s NaviCap ™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all trial objectives, demonstrating the NaviCap platform’s ab...